399 related articles for article (PubMed ID: 15504868)
21. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
Seignères B; Pichoud C; Martin P; Furman P; Trépo C; Zoulim F
Hepatology; 2002 Sep; 36(3):710-22. PubMed ID: 12198665
[TBL] [Abstract][Full Text] [Related]
22. In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine.
Bazmi HZ; Hammond JL; Cavalcanti SC; Chu CK; Schinazi RF; Mellors JW
Antimicrob Agents Chemother; 2000 Jul; 44(7):1783-8. PubMed ID: 10858331
[TBL] [Abstract][Full Text] [Related]
23. Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.
Ying C; Colonno R; De Clercq E; Neyts J
Antiviral Res; 2007 Mar; 73(3):192-6. PubMed ID: 17098296
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
26. The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection.
Margolis DM; Mukherjee AL; Fletcher CV; Hogg E; Ogata-Arakaki D; Petersen T; Rusin D; Martinez A; Mellors JW
AIDS; 2007 Oct; 21(15):2025-32. PubMed ID: 17885292
[TBL] [Abstract][Full Text] [Related]
27. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
28. High-performance liquid chromatographic determination of (-)-beta-D-2,6-diaminopurine dioxolane and its metabolite, dioxolane guanosine, using ultraviolet and on-line radiochemical detection.
Rajagopalan P; Gao Z; Chu CK; Schinazi RF; McClure HM; Boudinot FD
J Chromatogr B Biomed Appl; 1995 Oct; 672(1):119-24. PubMed ID: 8590923
[TBL] [Abstract][Full Text] [Related]
29. Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitro.
Tremblay CL; Poulin DL; Hicks JL; Selliah S; Chamberland A; Giguel F; Kollmann CS; Chou TC; Dong H; Hirsch MS
Antimicrob Agents Chemother; 2003 Nov; 47(11):3644-6. PubMed ID: 14576137
[TBL] [Abstract][Full Text] [Related]
30. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir.
Ying C; De Clercq E; Nicholson W; Furman P; Neyts J
J Viral Hepat; 2000 Mar; 7(2):161-5. PubMed ID: 10760047
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of dengue virus replication by mycophenolic acid and ribavirin.
Takhampunya R; Ubol S; Houng HS; Cameron CE; Padmanabhan R
J Gen Virol; 2006 Jul; 87(Pt 7):1947-1952. PubMed ID: 16760396
[TBL] [Abstract][Full Text] [Related]
34. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
36. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
37. A putative role for inosine 5' monophosphate dehydrogenase (IMPDH) in Leishmania amazonensis programmed cell death.
Pitaluga AN; Moreira ME; Traub-Csekö YM
Exp Parasitol; 2015 Feb; 149():32-8. PubMed ID: 25499513
[TBL] [Abstract][Full Text] [Related]
38. Sindbis virus mutants resistant to mycophenolic acid and ribavirin.
Scheidel LM; Durbin RK; Stollar V
Virology; 1987 May; 158(1):1-7. PubMed ID: 3033882
[TBL] [Abstract][Full Text] [Related]
39. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
40. Ribavirin: recent insights into antiviral mechanisms of action.
Reyes GR
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):651-6. PubMed ID: 12825459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]